Cargando…

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model

Disclosure: Y. Chen: None. H. Wu: None. B.A. Gower: None. R. Azziz: Advisory Board Member; Self; Arora Forge. Consulting Fee; Self; Fortress Biotech, Spruce Biosciences, Core Access Surgical Technologies, Rani Therapeutics. Grant Recipient; Self; Ferring Pharmaceuticals, Foundation for Research and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yen-Hao, Wu, Hsiao-Li, Gower, Barbara Ann, Azziz, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555862/ http://dx.doi.org/10.1210/jendso/bvad114.1691

Ejemplares similares

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome
por: Azziz, Ricardo, et al.
Publicado: (2022)

SAT368 Severe Hyperandrogenism in a Young Woman with Elevated BMI: A Case Study of The Role of Weight Loss in The Management of PCOS
por: Ortega, Susel Rodriguez, et al.
Publicado: (2023)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

SAT374 Indirect and Intangible Burden of PCOS: A Patient Advocacy Organization Study
por: Thai, Linda, et al.
Publicado: (2023)

miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance
por: Chen, Yen-Hao, et al.
Publicado: (2013)

SAT364 A Rare Cause of Hyperandrogenism in a Premenopausal Woman
por: Musa Penna, Laurianne El, et al.
Publicado: (2023)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
por: Chavez, Luis, et al.
Publicado: (2019)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

FRI458 Rare Pathogenic Missense Variants in LMNA Identified in Women with Polycystic Ovary Syndrome (PCOS)
por: Bauer, Rosemary, et al.
Publicado: (2023)

SAT383 Case Study: Impact of Weight Reduction and Oral Contraceptive Pills on Hyperandrogenism
por: Syeda, Asma, et al.
Publicado: (2023)

SAT358 Race And Ethnicity Of Women With 21-hydroxylase Deficient Non-classic Adrenal Hyperplasia (NCAH) Compared With PCOS
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

Skeletal Muscle Health in Polycystic Ovary Syndrome: Protective Effect of Hyperandrogenism or Detrimental Effect of Insulin Resistance? A Systematic Review and Meta-Analysis
por: Kazemi, Maryam, et al.
Publicado: (2021)

SAT-017 Relationship Between Vitamin D Levels and Signs of Polycystic Ovary Syndrome
por: Smykalova, Anastasia, et al.
Publicado: (2020)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

Post Menopausal Hyperandrogenism: A Case of a Steroid Cell Tumor of the Ovary
por: Hassan Nelson, Lauren Juliette, et al.
Publicado: (2021)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

SUN-013 Cardiometabolic Profile of Brazilian Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis
por: Marchesan, Lucas Bandeira, et al.
Publicado: (2020)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

Lifestyle, Anxiety,Depression, and Clinical Profile in Women With Polycystic Ovary Syndrome: Initial Results From the Brazilian PCOS Study
por: Spritzer, Poli Mara, et al.
Publicado: (2021)

SAT360 Ovarian Vein Sampling in a Pre-menopausal Woman with Hyperandrogenism: Characterization of Hormonal Profiles
por: Hu, Tina Y, et al.
Publicado: (2023)

SAT-018 Androgen Actions in Adipose Tissue and the Brain Are Key Mediators in the Development of Polycystic Ovary Syndrome
por: Cox, Madeleine J, et al.
Publicado: (2020)

SAT-015 Incidence and Predictors of Hypertension in a Cohort of Australian Women with and Without Polycystic Ovary Syndrome
por: Kakoly, Nadira Sultana, et al.
Publicado: (2020)

SAT356 Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity
por: Lo, Jaclyn S, et al.
Publicado: (2023)

SAT357 Rising Incidence, Health Resource Utilization and Costs of Polycystic Ovary Syndrome in the United Kingdom
por: Berni, Tom, et al.
Publicado: (2023)

Association between ACE gene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls
por: sun, Jing, et al.
Publicado: (2009)

OR31-01 A Randomized Controlled Trial of a Lifestyle Intervention with Longitudinal Follow up on Ovarian Dysmorphology, Hyperandrogenism, and Menstrual Irregularity in Women with Polycystic Ovary Syndrome
por: Kazemi, Maryam, et al.
Publicado: (2020)

THU643 Hyperandrogenism Caused By A Steroid Cell Tumor Of The Ovary In A Postmenopausal Woman
por: Mon Myint, Myat Su, et al.
Publicado: (2023)

SAT-023 Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study
por: Kazemi, Maryam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n6gllcc6r6iqlp88331qua8374